HRS-2261

· Guangdong Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-2261, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough [Phase 2]